Joseph Baroldi Ionis Pharmaceuticals Inc (IONS) insider trading activity

Joseph Baroldi is EVP, Chief Business Officer of IONIS PHARMACEUTICALS INC. Currently has a direct ownership of 30,301 shares of IONS, which is worth approximately $2.16 Million. The most recent transaction as insider was on Oct 06, 2025, when has been sold 1,625 shares (Common Stock) at a price of $69.37 per share, resulting in proceeds of $112,726. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.3K

5.09% 3M change

54.35% 12M change

Total Value Held $2.16 Million

Joseph Baroldi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 06 2025	SELL Open market or private sale	$112,726 $69.37 p/Share	1,625 Reduced 5.09%	30,301 Common Stock
Oct 02 2025	SELL Open market or private sale	$1,020,150 $68.01 p/Share	15,000 Reduced 31.97%	31,926 Common Stock
Oct 02 2025	BUY Exercise of conversion of derivative security	$477,000 $31.8 p/Share	15,000 Added 24.22%	46,926 Common Stock
Sep 09 2025	SELL Open market or private sale	$742,812 $62.16 p/Share	11,950 Reduced 27.24%	31,926 Common Stock
Sep 09 2025	BUY Exercise of conversion of derivative security	$380,010 $31.8 p/Share	11,950 Added 21.41%	43,876 Common Stock
Sep 05 2025	SELL Open market or private sale	$15,500 $62.0 p/Share	250 Reduced 0.78%	31,926 Common Stock
Sep 05 2025	BUY Exercise of conversion of derivative security	$7,950 $31.8 p/Share	250 Added 0.77%	32,176 Common Stock
Sep 03 2025	SELL Open market or private sale	$1,986,040 $60.55 p/Share	32,800 Reduced 65.96%	16,926 Common Stock
Sep 03 2025	BUY Exercise of conversion of derivative security	$1,043,040 $31.8 p/Share	32,800 Added 50.68%	31,926 Common Stock
Apr 16 2025	SELL Open market or private sale	$111,555 $28.4 p/Share	3,928 Reduced 10.96%	31,926 Common Stock
Apr 15 2025	BUY Exercise of conversion of derivative security	-	10,837 Added 23.21%	35,854 Common Stock
Jan 16 2025	SELL Open market or private sale	$111,212 $32.7 p/Share	3,401 Reduced 11.97%	25,017 Common Stock
Jan 15 2025	BUY Exercise of conversion of derivative security	-	8,787 Added 23.62%	28,418 Common Stock
Apr 16 2024	SELL Open market or private sale	$166,649 $41.6 p/Share	4,006 Reduced 16.95%	19,631 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	-	10,838 Added 31.44%	23,637 Common Stock
Jan 17 2024	SELL Open market or private sale	$73,613 $50.42 p/Share	1,460 Reduced 10.24%	12,799 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	-	3,688 Added 20.55%	14,259 Common Stock
Apr 18 2023	SELL Open market or private sale	$141,620 $36.5 p/Share	3,880 Reduced 26.85%	10,571 Common Stock
Apr 17 2023	BUY Exercise of conversion of derivative security	-	10,838 Added 42.86%	14,451 Common Stock

Also insider at

RNA

Avidity Biosciences, Inc. Healthcare

Chief Operating Officer

Joseph Baroldi

EVP, Chief Business Officer

Carlsbad, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IONS shares.

Notify only if

Value

Insider Trading

Get notified when an Ionis Pharmaceuticals Inc insider buys or sells IONS shares.

Notify only if

Operation

Value

Type

News

Receive news related to IONIS PHARMACEUTICALS INC

Track Activities on IONS

Account